FDA Letter API

Grand Vapors

Letter data

Company
Grand Vapors
Recipient
Karisa Jones | Grand Vapors | United States | info@grandvapors.com | karisajones1414@gmail.com
Issue date
2021-07-30
Posted date
Not available
FDA office
Center for Tobacco Products
Subject
Not available
Product
Tobacco
CMS ID
613962
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Grand Vapors MARCS-CMS 613962 — July 30, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Product: Tobacco Recipient: Recipient Name Karisa Jones Grand Vapors United States info@grandvapors.com karisajones1414@gmail.com Issuing Office: Center for Tobacco Products United States Dear Karisa Jones, The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions following the issuance of our Warning Letter dated March 26, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.grandvapors.com. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Sincerely, /S/ Mallory Bowling Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products VIA Electronic Mail cc: GoDaddy.com LLC abuse@godaddy.com Cloudflare, Inc. abuse@cloudflare.com Content current as of: 08/16/2023 Regulated Product(s) Tobacco